Home › Bristol-Myers Squibb To Acquire Padlock Therapeutics, Inc.
 

Keywords :   


Bristol-Myers Squibb To Acquire Padlock Therapeutics, Inc.

2016-03-30 03:53:43| drugdiscoveryonline Home Page

Bristol-Myers Squibb Company and Padlock Therapeutics, Inc. announced recently that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the outstanding capital stock of Padlock, a private, Cambridge, Massachusetts-based biotechnology company dedicated to creating new medicines to treat destructive autoimmune diseases

Tags: acquire therapeutics squibb padlock

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 7
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
More »